Low cost of switching suppliers (GlaxoSmithKline)

Home Five Forces Analysis Index GlaxoSmithKline - Five Forces Analysis Low cost of switching suppliers (GlaxoSmithKline)

Last Updated by Anonymous | Update This Page Flag this page Delete This Page

Add New Five Forces Analysis | Feedback

rating: 0+–x

The easier it is to switch suppliers, the less bargaining power they have. Low supplier switching costs positively affect GlaxoSmithKline. … "Low cost of switching suppliers (GlaxoSmithKline)" has a significant impact, so an analyst should put more weight into it. "Low cost of switching suppliers (GlaxoSmithKline)" will have a long-term positive impact on the this entity, which adds to its value. "Low cost of switching suppliers (GlaxoSmithKline)" is an easily defendable qualitative factor, so competing institutions will have a difficult time overcoming it. This statements will have a short-term negative impact on this entity, which subtracts from its value. This qualitative factor will lead to an increase in costs. This statement will lead to a decrease in profits. "Low cost of switching suppliers (GlaxoSmithKline)" is an easy qualitative factor to overcome, so the investment will not have to spend much time trying to overcome this issue.
Five Forces Analysis Survey

This statement has a significant impact?

Has a positive impact over the long term?

Has a negative impact over the long term?

Has a positive impact over the short term?

Has a negative impact over the short term?

This statement leads to reduced costs?

This statement leads to increased costs?

This statement leads to increased profits?

This statement leads to decreased profits?

Easy to defend this advantage?

Easily to overcome this disadvantage?

Difficult to defend advantage?

Difficult to overcome this disadvantage?

Affected Investments